Rheumatism In Populations

Rheumatism in Populations provides information pertinent to rheumatic diseases. This book covers certain systemic orders such as the systemic lupus erythematosus that frequently affect the joints. Organized into 16 chapters, this book begins with an overview of the history of the epidemiology of rheumatism. This text then examines the prevalence of rheumatoid arthritis in screened sample and in total population samples. Other chapters consider the relative significance of rheumatic disorders as a cause of loss of work as revealed by the National Health Insurance statistics. This book discusses as well the pathology of disc disorders, osteoarthritis, rheumatoid arthritis, benign polyarthritis, metabolic joint disease, general connective tissue diseases, and immune deficiency diseases. The final chapter deals with diagnostic criteria for population investigations of rheumatoid arthritis. This book is a valuable resource for rheumatologists, physicians, and medico-social workers. Readers who are interested in the study of rheumatic diseases will also find this book useful.

This major reference work is the first comprehensive text to review in detail the data currently available on the epidemiology of the main rheumatic and muscoskeletal diseases. The problems of disease definition and criteria are considered with data on the occurrence of these diseases, both prevalence and incidence, and their variation with age, sex, geographical area, ethnic group, and trends over time. The results of epidemiological investigations,looking at both genetic and environmental risk factors, are considered and the impact of specific diseases of survival is also considered. Covering 15 disease areas from inflammatory joint disease and connective tissue disease to degenerative joint disease and non articular conditions, such as low back pain and carpel tunnel syndrome, this is the only text available which offers full coverage of the subject with a truly international perspective.

This issue covers the latest developments in the understanding of rheumatoid arthritis at the early stage. Treatments such as with newer biologic agents and conventional disease-modifying antirheumatic drugs are reviewed. Also included are articles on imaging modalities as a means of identifying those in the early stages and monitoring response to treatment.

This issue of Rheumatic Disease Clinics, guest edited by Dr. Candace Feldman, will Health Disparities in Rheumatic Diseases. This issue is one of four selected each year by series Consulting Editor, Dr. Michael Weisman. Topics discussed in this issue include, but are not limited to: Disparities in Rheumatology Through the Lens of Critical Race Theory; Use of Quality Metrics to Identify Disparities in Lupus Care; The Role of Individual and Area-level Poverty on Lupus Disparities; Disparities in Lupus Care and Outcomes among U.S. Medicaid Beneficiaries; Disparities in Rheumatoid Arthritis Care; Disparities in Childhood-onset Lupus and Mental Health Care for Pediatric Lupus Patients; Disparities in Rheumatic Disease Care, Access and Outcomes in the First Nations Population; Impact of Psychosocial Factors on RA and Lupus Health Disparities; Racial and gender disparities among patients with Gout; Racial/ethnic and geographic disparities in knee and hip osteoarthritis; Racial/ethnic Disparities in Osteoarthritis Management; Racial disparities in systemic sclerosis; Community-engaged Research: Lupus Conversations; Leveraging Telemedicine as an Approach to Address Rheumatic Disease Health Disparities; Understanding the Role and Challenges of Patient Preferences in Disparities in Rheumatic Disease Care; Designing an Intervention to Improve Management and Care Coordination for High Risk Lupus Patients; Greatest Challenges and Strategies to Achieve Equitable Rheumatologic Care Across the World, among others.

Paediatric Rheumatology is an indispensible resource for the identification and management of specific rheumatological disorders. As well as covering common and rare rheumatological problems, there are also chapters on investigations and emergencies, designed for quick reference. The handbook includes dedicated topics on systemic diseases affecting rheumatology; the relevant clinical guidelines and information needed for a rheumatologist to successfully management a young patient; and, a coloured section for guidance on rash-related investigations. Paediatric Rheumatology is also fully endorsed by the British Society for Paediatric and Adolescent Rheumatology and the UK Paediatric Rheumatology Clinical Studies Group.

Vaccines have made it possible to eradicate the scourge of smallpox, promise the same for polio, and have profoundly reduced the threat posed by other diseases such as whooping cough, measles, and meningitis. What is next? There are many pathogens, autoimmune diseases, and cancers that may be promising targets for vaccine research and development. This volume provides an analytic framework and quantitative model for evaluating disease conditions that can be applied by those setting priorities for vaccine development over the coming decades. The committee describes an approach for comparing potential new vaccines based on their impact on morbidity and mortality and on the costs of both health care and vaccine development. The book examines: Lessons to be learned from the polio experience. Scientific advances that set the stage for new vaccines. Factors that affect how vaccines are used in the population. Value judgments and ethical questions raised by comparison of health needs and benefits. The committee provides a way to compare different forms of illness and set vaccine priorities without assigning a monetary value to lives. Their recommendations will be important to anyone involved in science policy and public health planning: policymakers, regulators, health care providers, vaccine manufacturers, and researchers.

In the present monograph, we offer current insights into polymyalgia rheumatica and giant cell arthritis. Both diseases are typical for advanced age, and their incidences increase with aging. Both diseases are a center point of interest not only for rheu- tologists, gerontologists, ophthalmologists or neurologists, but also for general prac- tioners. Early diagnosis and rapid treatment, mainly with glucocorticoids can save one of the most precious senses-vision. Damage to other organs (heart, aorta, co- nary arteries, liver, lungs, kidneys), which are supplied by the arteries affected by ischemic syndrome in the setting of giant cell arthritis, has serious consequences as well. Late diagnosis of giant cell arthritis can have fatal consequences for affected patients. It is a matter of fact that the human population is aging. Therefore, more attention has to be paid not only to diagnosis, clinical course and treatment of rheumatic d- eases in elderly, but also to their genetic, immunologic, endocrinologic, chronobiologic mechanisms, and state-of-the-art diagnostic modalities. I am convinced that the int- disciplinary research of the diseases will allow us to diagnose and treat the rheumatic diseases even faster and more effectively in the future.

This brand new textbook of rheumatoid arthritis (RA) is an important addition to the Oxford Textbooks in Rheumatology series, and provides a comprehensive overview of both the scientific and clinical aspects of the disease. Divided into eight sections - from the history, diagnosis, and epidemiology of the disease, through the pathogenesis, clinical presentation, and assessment to treatments and management strategies, both drug- and non-drug based - each chapter is written by leading clinicians and scientists in the field to deliver a contemporary view of RA. During the past two decades there have been revolutionary changes in the understanding and management of rheumatoid arthritis, in particular the development of biological treatments. This has had wide-ranging effects on almost all aspects of treatment, from effectiveness and intensity to the nature and the cost. Providing a comprehensive account of the modern ideas about the disease, the Oxford Textbook of Rheumatoid Arthritis is a key new addition to the literature, with each chapter providing a detailed background, key recent advances, and areas of doubt and future developments. Featuring over 170 photographs, radiological images, and clinical charts to aid both diagnosis and illustrate the rationale behind key scientific studies, this new title will prove an indispensable resource for specialist rheumatologists, trainees in rheumatology, and other members of the multi-disciplinary team.